For investors looking for momentum, SPDR Dow Jones REIT ETF RWR probably on the radar. The fund just hit a 52-week high and is up about 48.5% from its 52-week low of $ 74.34 per share.
But is this ETF expecting even more profits? Let’s take a quick look at the fund and its short-term outlook to better understand where it might be heading:
RWR in focus
It offers access to the wider US real estate sector with key assets in REITs for offices, REITs for residential buildings, REITs for retail, and REITs for healthcare. The ETF charges 25 bps. in year.
Recently, the real estate market should be closely monitored. Low rates fueled by the Fed’s dovish and fears over the Covid-19 delta option are keeping rates low and stimulating rate-sensitive sectors such as real estate.
Rising home values are also a plus for real estate stocks and ETFs. The rise in house prices also boosted the demand for rent. The labor market is still far from stable. This means that the demand for rental properties is likely to remain strong from middle- to low-income consumers.
More benefits ahead?
RWR is currently ranked 3rd in the Zacks ETF (Hold) with an average risk outlook. The fund has positive weighted alpha 44.86… As such, there are good prospects ahead for those looking to straddle this growing ETF a little more.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surpass $ 775 billion by 2024 as scientists develop treatments for thousands of diseases. They also find ways to edit the human genome to literally erase our vulnerability to these diseases.
Zachs just released The Age of Biology: 7 Biotech Stocks You Should Buy Right Now to help investors profit from 7 stocks ready for outperformance. Our recent biotech recommendation yielded + 50%, + 83% and + 164% gains in just 2 months. The stocks in this report could be even better.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.